The Multiplex PCR Company
Multiplex qPCR implemented on the walk-away ICEPlex instrument — Truly, a Next Generation qPCR Platform
Find the Application that Interests You »Who is PrimeraDx?
PrimeraDx is a molecular diagnostics company that has developed, and is commercializing, a novel, game-changing clinical platform which combines PCR with capillary electrophoresis.
The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative, answers to the clinic.
The company is pursuing a two-pronged strategy to sell the system in an Open Platform Mode to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion and enabling diagnostic products.
Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes.
PrimeraDx’s technology represents the next generation of quantitative PCR.
PrimeraDx is ISO 13485: 2003 certified.
Visit Us At
-
Annual Society of Clinical Oncology (ASCO)
- Chicago, IL
- June 1–5, 2012Booth #7118
-
American Association for Clinical Chemistry (AACC)
- Los Angeles, CA
- July 15–19, 2012
-
Next Generation Dx Summit
- Washington DC
- August 21–23, 2012